Pharmacological interventions for spinal cord injury: Where do we stand? How might we step forward?

Pharmacology and Therapeutics

Volumn 132, Issue 1, 2011, Pages 15-29

  Rabchevsky, Alexander G ^a   Patel, Samir P ^a   Springer, Joe E ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Clinical trials; Erythropoietin; Fampridine; Minocycline; Mitochondria; Riluzole

Indexed keywords

4 AMINOPYRIDINE; BACLOFEN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BOTULINUM TOXIN A; CANNABIS; CEFTRIAXONE; CIPROFLOXACIN; CRANBERRY EXTRACT; CYCLOSPORIN A; CYCLOSPORIN A [4 N METHYLISOLEUCINE]; DARIFENACIN; ERYTHROPOIETIN; GLYCOPYRRONIUM BROMIDE; LEVACECARNINE; METHYLPREDNISOLONE SODIUM SUCCINATE; MINOCYCLINE; MORPHINE SULFATE; N(G) NITROARGININE METHYL ESTER; NEOSTIGMINE; OXYBUTYNIN; PRAZOSIN; PREGABALIN; RILUZOLE; SALSALATE; SOLIFENACIN; TROSPIUM CHLORIDE; UNINDEXED DRUG; VARDENAFIL; VENLAFAXINE; ZOLEDRONIC ACID;

AGITATION; APOPTOSIS; AUTONOMIC DYSREFLEXIA; BONE DENSITY; CYTOSOL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSESTHESIA; ERECTILE DYSFUNCTION; HEADACHE; HUMAN; INSOMNIA; MAJOR DEPRESSION; MONOCYTE; MULTIPLE SCLEROSIS; NAUSEA; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; OSTEOLYSIS; OVERACTIVE BLADDER; PARESTHESIA; PATHOPHYSIOLOGY; PERFUSION PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEIZURE; SENSORIMOTOR FUNCTION; SHOCK; SIDE EFFECT; SPASTICITY; SPINAL CORD INJURY; URINARY TRACT INFECTION; VASCULITIS;

CLINICAL TRIALS AS TOPIC; HUMANS; MITOCHONDRIA; MOLECULAR TARGETED THERAPY; NEUROPROTECTIVE AGENTS; PRACTICE GUIDELINES AS TOPIC; RECOVERY OF FUNCTION; SPINAL CORD INJURIES;

EID: 79960570561     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.05.001     Document Type: Review

References (315)

1. M. Adams, and J.F. Cavanagh International Campaign for Cures of Spinal Cord Injury Paralysis (ICCP): another step forward for spinal cord injury research Spinal Cord 42 5 2004 273 280 (Pubitemid 38903489)
2. L. Aigner, and U. Bogdahn TGF-beta in neural stem cells and in tumors of the central nervous system Cell Tissue Res 331 1 2008 225 241 (Pubitemid 350265484)
3. J.K. Alexander, and P.G. Popovich Neuroinflammation in spinal cord injury: therapeutic targets for neuroprotection and regeneration Prog Brain Res 175 2009 125 137
4. M.S. Alexander, F. Biering-Sorensen, D. Bodner, N.L. Brackett, D. Cardenas, and S. Charlifue International standards to document remaining autonomic function after spinal cord injury Spinal Cord 47 1 2009 36 43
5. E. Alves, Z. Binienda, F. Carvalho, C.J. Alves, E. Fernandes, and M. de Lourdes Bastos Acetyl-l-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain Neuroscience 158 2 2009 514 523
6. A.P. Amar, and M.L. Levy Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury Neurosurgery 44 5 1999 1027 1040 (Pubitemid 29202863)
7. D.K. Anderson, M. Beattie, A. Blesch, J. Bresnahan, M. Bunge, and D. Dietrich Recommended guidelines for studies of human subjects with spinal cord injury Spinal Cord 43 8 2005 453 458 (Pubitemid 41192422)
8. K.D. Anderson Targeting recovery: priorities of the spinal cord-injured population J Neurotrauma 21 10 2004 1371 1383 (Pubitemid 39435314)
9. A. Andreyev, and G. Fiskum Calcium induced release of mitochondrial cytochrome c by different mechanisms selective for brain versus liver Cell Death Differ 6 9 1999 825 832 (Pubitemid 29488080)
10. D.P. Ankeny, and P.G. Popovich Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury Neuroscience 158 3 2009 1112 1121
11. Anonymous Acetyl-l-carnitine Altern Med Rev 4 6 1999 438 441
12. Y. Arishima, T. Setoguchi, I. Yamaura, K. Yone, and S. Komiya Preventive effect of erythropoietin on spinal cord cell apoptosis following acute traumatic injury in rats Spine 31 21 2006 2432 2438 (Phila Pa 1976) (Pubitemid 44527025)
13. D. Ashton, R. Willems, J. Wynants, J. Van Reempts, R. Marrannes, and G. Clincke Altered Na(+)-channel function as an in vitro model of the ischemic penumbra: action of lubeluzole and other neuroprotective drugs Brain Res 745 1-2 1997 210 221 (Pubitemid 27055764)
14. O. Ates, S.R. Cayli, I. Gurses, Y. Turkoz, O. Tarim, and C.O. Cakir Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury J Clin Neurosci 14 7 2007 658 665 (Pubitemid 46783492)
15. T. Aureli, C. Puccetti, M.E. Di Cocco, A. Arduini, R. Ricciolini, and M. Scalibastri Entry of [(1,2-13C2)acetyl]-l-carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious, freely moving rats Eur J Biochem 263 1 1999 287 293 (Pubitemid 29313866)
16. R.D. Azbill, X. Mu, and J.E. Springer Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes Brain Res 871 2 2000 175 180 (Pubitemid 30433869)
17. C.P. Baines, R.A. Kaiser, N.H. Purcell, N.S. Blair, H. Osinska, and M.A. Hambleton Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death Nature 434 7033 2005 658 662 (Pubitemid 40488559)
18. A.P. Ball, R.B. Hopkinson, I.D. Farrell, J.G. Hutchison, R. Paul, and R.D. Watson Human botulism caused by Clostridium botulinum type E: the Birmingham outbreak Q J Med 48 191 1979 473 491 (Pubitemid 10200363)
19. F.M. Bany-Mohammed, S. Slivka, and M. Hallman Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits Pediatr Res 40 3 1996 381 387 (Pubitemid 26282569)
20. D.C. Baptiste, and M.G. Fehlings Pharmacological approaches to repair the injured spinal cord J Neurotrauma 23 3-4 2006 318 334 (Pubitemid 43726313)
21. L. Barbeito, A. Cheramy, G. Godeheu, J.M. Desce, and J. Glowinski Glutamate receptors of a quisqualate-kainate subtype are involved in the presynaptic regulation of dopamine release in the cat caudate nucleus in vivo Eur J Neurosci 2 4 1990 304 311 (Pubitemid 20147069)
22. P. Barneoud, M. Mazadier, J.M. Miquet, S. Parmentier, P. Dubedat, and A. Doble Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat Neuroscience 74 4 1996 971 983 (Pubitemid 26313341)
23. C.A. Barnes, A.L. Markowska, D.K. Ingram, H. Kametani, E.L. Spangler, and V.J. Lemken Acetyl-l-carnitine. 2: effects on learning and memory performance of aged rats in simple and complex mazes Neurobiol Aging 11 5 1990 499 506 (Pubitemid 20297142)
24. D. Bartholdi, and M.E. Schwab Methylprednisolone inhibits early inflammatory processes but not ischemic cell death after experimental spinal cord lesion in the rat Brain Res 672 1-2 1995 177 186
25. E. Basso, L. Fante, J. Fowlkes, V. Petronilli, M.A. Forte, and P. Bernardi Properties of the permeability transition pore in mitochondria devoid of cyclophilin D J Biol Chem 280 19 2005 18558 18561 (Pubitemid 41379552)
26. D.L. Behrmann, J.C. Bresnahan, and M.S. Beattie Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone, U-74006F and YM-14673 Exp Neurol 126 1 1994 61 75 (Pubitemid 24131103)
27. J. Benavides, J.C. Camelin, N. Mitrani, F. Flamand, A. Uzan, and J.J. Legrand 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission-II. Biochemical properties Neuropharmacology 24 11 1985 1085 1092 (Pubitemid 16176969)
28. E. Benoit, and D. Escande Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre Pflugers Arch 419 6 1991 603 609
29. G. Bensimon, L. Lacomblez, and V. Meininger A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group N Engl J Med 330 9 1994 585 591 (Pubitemid 24065791)
30. P. Bernardi The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death Biochim Biophys Acta 1275 1-2 1996 5 9 (Pubitemid 26233155)
31. P. Bernardi, and V. Petronilli The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal J Bioenerg Biomembr 28 2 1996 131 138 (Pubitemid 26131526)
32. P. Bernardi, R. Colonna, P. Costantini, O. Eriksson, E. Fontaine, and F. Ichas The mitochondrial permeability transition Biofactors 8 3-4 1998 273 281 (Pubitemid 29021358)
33. M. Bernaudin, H.H. Marti, S. Roussel, D. Divoux, A. Nouvelot, and E.T. MacKenzie A potential role for erythropoietin in focal permanent cerebral ischemia in mice J Cereb Blood Flow Metab 19 6 1999 643 651 (Pubitemid 30161216)
34. C.T. Bever, and S.I. Judge Sustained-release fampridine for multiple sclerosis Expert Opin Investig Drugs 18 7 2009 1013 1024
35. C.T. Bever Jr., D. Young, P.A. Anderson, A. Krumholz, K. Conway, and J. Leslie The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trial Neurology 44 6 1994 1054 1059 (Pubitemid 24188176)
36. A.R. Blight Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury Brain Res Bull 22 1 1989 47 52
37. A.R. Blight Miracles and molecules-progress in spinal cord repair Nat Neurosci 5 2002 1051 1054 Suppl (Pubitemid 35247197)
38. Y.E. Bogaert, K.F. Sheu, P.R. Hof, A.M. Brown, J.P. Blass, and R.E. Rosenthal Neuronal subclass-selective loss of pyruvate dehydrogenase immunoreactivity following canine cardiac arrest and resuscitation Exp Neurol 161 1 2000 115 126 (Pubitemid 30136534)
39. E. Bonavita Study of the efficacy and tolerability of l-acetylcarnitine therapy in the senile brain Int J Clin Pharmacol Ther Toxicol 24 9 1986 511 516 (Pubitemid 16014637)
40. B.O. Boran, A. Colak, and M. Kutlay Erythropoietin enhances neurological recovery after experimental spinal cord injury Restor Neurol Neurosci 23 5-6 2005 341 345 (Pubitemid 41746167)
41. C.M. Bowe, J.D. Kocsis, E.F. Targ, and S.G. Waxman Physiological effects of 4-aminopyridine on demyelinated mammalian motor and sensory fibers Ann Neurol 22 2 1987 264 268 (Pubitemid 17122589)
42. M.B. Bracken Methylprednisolone in the management of acute spinal cord injuries Med J Aust 153 6 1990 368 (Pubitemid 20297099)
43. M.B. Bracken, M.J. Shepard, W.F. Collins, T.R. Holford, W. Young, and D.S. Baskin A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study New Engl J Med 322 20 1990 1405 1411 (Pubitemid 20152525)
44. M.B. Bracken, M.J. Shepard, W.F. Collins Jr., T.R. Holford, D.S. Baskin, and H.M. Eisenberg Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study J Neurosurg 76 1 1992 23 31
45. M.B. Bracken, M.J. Shepard, T.R. Holford, L. Leo-Summers, E.F. Aldrich, and M. Fazl Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial Nat Acute Spinal Cord Inj Study JAMA 277 20 1997 1597 1604 (Pubitemid 27231191)
46. E.J. Bradbury, and S.B. McMahon Spinal cord repair strategies: why do they work? Nat Rev Neurosci 7 8 2006 644 653 (Pubitemid 44106746)
47. J.M. Braughler, and E.D. Hall Involvement of lipid peroxidation in CNS injury J Neurotrauma 9 Suppl 1 1992 S1 S7
48. M.L. Brines, P. Ghezzi, S. Keenan, D. Agnello, N.C. de Lanerolle, and C. Cerami Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci USA 97 19 2000 10526 10531
49. K.M. Broekemeier, and D.R. Pfeiffer Inhibition of the mitochondrial permeability transition by cyclosporin A during long time frame experiments: relationship between pore opening and the activity of mitochondrial phospholipases Biochemistry 34 50 1995 16440 16449 (Pubitemid 26006490)
50. N. Brustovetsky, T. Brustovetsky, R. Jemmerson, and J.M. Dubinsky Calcium-induced cytochrome c release from CNS mitochondria is associated with the permeability transition and rupture of the outer membrane J Neurochem 80 2 2002 207 218 (Pubitemid 34809366)
51. H.M. Bryson, B. Fulton, and P. Benfield Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis Drugs 52 4 1996 549 563 (Pubitemid 26340539)
52. V. Calabrese, A. Ravagna, C. Colombrita, G. Scapagnini, E. Guagliano, and M. Calvani Acetylcarnitine induces heme oxygenase in rat astrocytes and protects against oxidative stress: involvement of the transcription factor Nrf2 J Neurosci Res 79 4 2005 509 521 (Pubitemid 40283351)
53. M.C. Calcerrada, R.E. Catalan, and A.M. Martinez Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus Biochem Mol Biol Int 47 3 1999 529 535 (Pubitemid 29155089)
54. C. Cande, I. Cohen, E. Daugas, L. Ravagnan, N. Larochette, and N. Zamzami Apoptosis-inducing factor (AIF): a novel caspase-independent death effector released from mitochondria Biochimie 84 2-3 2002 215 222
55. D.D. Cardenas, J. Ditunno, V. Graziani, A.B. Jackson, D. Lammertse, and P. Potter Phase 2 trial of sustained-release fampridine in chronic spinal cord injury Spinal Cord 45 2 2007 158 168 (Pubitemid 46204264)
56. A. Carta, and M. Calvani Acetyl-l-carnitine: a drug able to slow the progress of Alzheimer's disease? Ann N Y Acad Sci 640 1991 228 232
57. A. Cetin, K. Nas, H. Buyukbayram, A. Ceviz, and G. Olmez The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats Eur Spine J 15 10 2006 1539 1544 (Pubitemid 44583667)
58. J. Chai, C. Du, J.W. Wu, S. Kyin, X. Wang, and Y. Shi Structural and biochemical basis of apoptotic activation by Smac/DIABLO Nature 406 6798 2000 855 862 (Pubitemid 30664254)
59. M. Chen, V.O. Ona, M. Li, R.J. Ferrante, K.B. Fink, and S. Zhu Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease [in process citation] Nat Med 6 7 2000 797 801 (Pubitemid 30469429)
60. A. Cheramy, L. Barbeito, G. Godeheu, and J. Glowinski Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo Neurosci Lett 147 2 1992 209 212
61. S. Chiechio, A. Caricasole, E. Barletta, M. Storto, M.V. Catania, and A. Copani l-Acetylcarnitine induces analgesia by selectively up-regulating mGlu2 metabotropic glutamate receptors Mol Pharmacol 61 5 2002 989 996 (Pubitemid 34441763)
62. T. Chikawa, T. Ikata, S. Katoh, Y. Hamada, K. Kogure, and K. Fukuzawa Preventive effects of lecithinized superoxide dismutase and methylprednisolone on spinal cord injury in rats: transcriptional regulation of inflammatory and neurotrophic genes J Neurotrauma 18 1 2001 93 103 (Pubitemid 32055459)
63. D.W. Choi Glutamate neurotoxicity and diseases of the nervous system Neuron 1 8 1988 623 634
64. A.M. Choo, J. Liu, Z. Liu, M. Dvorak, W. Tetzlaff, and T.R. Oxland Modeling spinal cord contusion, dislocation, and distraction: characterization of vertebral clamps, injury severities, and node of Ranvier deformations J Neurosci Methods 181 1 2009 6 17
65. T.J. Coderre, N. Kumar, C.D. Lefebvre, and J.S. Yu A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain J Neurochem 100 5 2007 1289 1299
66. P. Couratier, P. Sindou, F. Esclaire, E. Louvel, and J. Hugon Neuroprotective effects of riluzole in ALS CSF toxicity Neuroreport 5 8 1994 1012 1014 (Pubitemid 24138122)
67. M. Crompton The mitochondrial permeability transition pore and its role in cell death Biochem J 341 Pt 2 1999 233 249 (Pubitemid 29373645)
68. C. Dame, S.E. Juul, and R.D. Christensen The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential Biol Neonate 79 3-4 2001 228 235 (Pubitemid 32247092)
69. F.A. Davis, D. Stefoski, and J. Rush Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis Ann Neurol 27 2 1990 186 192 (Pubitemid 20086640)
70. S. Dhitavat, D. Ortiz, T.B. Shea, and E.R. Rivera Acetyl-l-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels Neurochem Res 27 6 2002 501 505
71. L. Di Cesare Mannelli, C. Ghelardini, M. Calvani, R. Nicolai, L. Mosconi, and E. Vivoli Protective effect of acetyl-l-carnitine on the apoptotic pathway of peripheral neuropathy Eur J Neurosci 26 4 2007 820 827 (Pubitemid 47274617)
72. L. Di Cesare Mannelli, C. Ghelardini, M. Calvani, R. Nicolai, L. Mosconi, and A. Toscano Neuroprotective effects of acetyl-l-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor J Neurosci Res 2008
73. A. Diaz-Ruiz, C. Rios, I. Duarte, D. Correa, G. Guizar-Sahagun, and I. Grijalva Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats Neurosci Lett 266 1 1999 61 64 (Pubitemid 29219756)
74. A. Diaz-Ruiz, C. Rios, I. Duarte, D. Correa, G. Guizar-Sahagun, and I. Grijalva Lipid peroxidation inhibition in spinal cord injury: cyclosporin-A vs methylprednisolone Neuroreport 11 8 2000 1765 1767 (Pubitemid 30350349)
75. D.J. Donnelly, and P.G. Popovich Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury Exp Neurol 209 2 2008 378 388 (Pubitemid 351181428)
76. W.H. Donovan, J.A. Halter, D.E. Graves, A.R. Blight, O. Calvillo, and M.T. McCann Intravenous infusion of 4-AP in chronic spinal cord injured subjects Spinal Cord 38 1 2000 7 15 (Pubitemid 30142551)
77. C. Du, M. Fang, Y. Li, L. Li, and X. Wang Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition Cell 102 1 2000 33 42
78. R.J. Dumont, D.O. Okonkwo, S. Verma, R.J. Hurlbert, P.T. Boulos, and D.B. Ellegala Acute spinal cord injury, part I: pathophysiologic mechanisms Clin Neuropharmacol 24 5 2001 254 264 (Pubitemid 32906712)
79. P.G. Ekert, J. Silke, C.J. Hawkins, A.M. Verhagen, and D.L. Vaux DIABLO promotes apoptosis by removing MIHA/XIAP from processed caspase 9 J Cell Biol 152 3 2001 483 490 (Pubitemid 34280232)
80. S. Erbayraktar, O. Yilmaz, N. Gokmen, and M. Brines Erythropoietin is a multifunctional tissue-protective cytokine Curr Hematol Rep 2 6 2003 465 470
81. A.G. Estevez, J.M. Stutzmann, and L. Barbeito Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures Eur J Pharmacol 280 1 1995 47 53
82. M. Ettaiche, K. Fillacier, C. Widmann, C. Heurteaux, and M. Lazdunski Riluzole improves functional recovery after ischemia in the rat retina Invest Ophthalmol Vis Sci 40 3 1999 729 736 (Pubitemid 29109452)
83. J. Evenhuis, S. Agoston, P.J. Salt, A.R. de Lange, W. Wouthuyzen, and W. Erdmann Pharmacokinetics of 4-aminopyridine in human volunteers. A preliminary study using a new GLC method for its estimation Br J Anaesth 53 6 1981 567 570 (Pubitemid 11075345)
84. A.I. Faden, and R.P. Simon A potential role for excitotoxins in the pathophysiology of spinal cord injury Ann Neurol 23 6 1988 623 626
85. A.I. Faden TRH analog YM-14673 improves outcome following traumatic brain and spinal cord injury in rats: dose-response studies Brain Res 486 2 1989 228 235 (Pubitemid 19135134)
86. A.I. Faden, J.A. Ellison, and L.J. Noble Effects of competitive and non-competitive NMDA receptor antagonists in spinal cord injury Eur J Pharmacol 175 2 1990 165 174 (Pubitemid 20030154)
87. X.Q. Fang, M. Fang, S.W. Fan, and C.L. Gu Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-beta Chin Med J (Engl) 122 14 2009 1631 1635
88. M. Farooque, Y. Olsson, and A. Holtz Effect of the 21-aminosteroid U74006F and methylprednisolone on motor function recovery and oedema after spinal cord compression in rats Acta Neurol Scand 89 1994 36 41 (Pubitemid 24084106)
89. J.W. Fawcett, A. Curt, J.D. Steeves, W.P. Coleman, M.H. Tuszynski, and D. Lammertse Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials Spinal Cord 45 3 2007 190 205 (Pubitemid 46340848)
90. M.G. Fehlings, and D. Louw Initial stabilization and medical management of acute spinal cord injury Am Fam Physician 54 1 1996 155 162 (Pubitemid 26242141)
91. M.G. Fehlings, and D.C. Baptiste Current status of clinical trials for acute spinal cord injury Injury 36 Suppl 2 2005 B113 B122
92. E. Fernandez, R. Pallini, E. Marchese, and G. Talamonti Experimental studies on spinal cord injuries in the last fifteen years Neurol Res 13 3 1991 138 159
93. B.W. Festoff, S. Ameenuddin, P.M. Arnold, A. Wong, K.S. Santacruz, and B.A. Citron Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury J Neurochem 97 5 2006 1314 1326 (Pubitemid 43725571)
94. G. Fiskum Mitochondrial participation in ischemic and traumatic neural cell death J Neurotrauma 17 10 2000 843 855
95. G. Fiskum, R.E. Rosenthal, V. Vereczki, E. Martin, G.E. Hoffman, and C. Chinopoulos Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress J Bioenerg Biomembr 36 4 2004 347 352 (Pubitemid 39619839)
96. C. Fox, A. Dingman, N. Derugin, M.F. Wendland, C. Manabat, and S. Ji Minocycline confers early but transient protection in the immature brain following focal cerebral ischemia-reperfusion J Cereb Blood Flow Metab 25 9 2005 1138 1149 (Pubitemid 41710740)
97. D.A. Fox, A.T. Poblenz, L. He, J.B. Harris, and C.J. Medrano Pharmacological strategies to block rod photoreceptor apoptosis caused by calcium overload: a mechanistic target-site approach to neuroprotection Eur J Ophthalmol 13 Suppl 3 2003 S44 S56
98. H. Friberg, M. Ferrand-Drake, F. Bengtsson, A.P. Halestrap, and T. Wieloch Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death J Neurosci 18 14 1998 5151 5159 (Pubitemid 28311932)
99. H. Friberg, and T. Wieloch Mitochondrial permeability transition in acute neurodegeneration Biochimie 84 2-3 2002 241 250
100. E. Fumagalli, P. Bigini, S. Barbera, M. De Paola, and T. Mennini Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease Exp Neurol 198 1 2006 114 128 (Pubitemid 43243750)
101. F. Fumagalli, L. Madaschi, P. Brenna, L. Caffino, G. Marfia, and A.M. Di Giulio Single exposure to erythropoietin modulates nerve growth factor expression in the spinal cord following traumatic injury: comparison with methylprednisolone Eur J Pharmacol 578 1 2008 19 27 (Pubitemid 350179757)
102. F.H. Geisler GM-1 ganglioside and motor recovery following human spinal cord injury J Emerg Med 11 1993 49 55 (Pubitemid 23054999)
103. N.T. Gentile, and T.K. McIntosh Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental central nervous system injury Ann Emerg Med 22 6 1993 1028 1034 (Pubitemid 23163046)
104. O. Ghirardi, S. Milano, M.T. Ramacci, and L. Angelucci Long-term acetyl-l-carnitine preserves spatial learning in the senescent rat Prog Neuropsychopharmacol Biol Psychiatry 13 1-2 1989 237 245 (Pubitemid 19120552)
105. A. Gorio, N. Gokmen, S. Erbayraktar, O. Yilmaz, L. Madaschi, and C. Cichetti Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma Proc Natl Acad Sci USA 99 14 2002 9450 9455 (Pubitemid 34764634)
106. A. Gorio, L. Madaschi, B. Di Stefano, S. Carelli, A.M. Di Giulio, and S. De Biasi Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury Proc Natl Acad Sci USA 102 45 2005 16379 16384 (Pubitemid 41688922)
107. A. Gorostizaga, L. Brion, P. Maloberti, F.C. Maciel, E.J. Podesta, and C. Paz Heat shock triggers MAPK activation and MKP-1 induction in Leydig testicular cells Biochem Biophys Res Commun 327 1 2005 23 28 (Pubitemid 40051346)
108. P. Grant, J.Y. Song, and S.E. Swedo Review of the use of the glutamate antagonist riluzole in psychiatric disorders and a description of recent use in childhood obsessive-compulsive disorder J Child Adolesc Psychopharmacol 20 4 2010 309 315
109. G. Grasso, A. Sfacteria, F. Meli, V. Fodale, M. Buemi, and D.G. Iacopino Neuroprotection by erythropoietin administration after experimental traumatic brain injury Brain Res 1182 2007 99 105 (Pubitemid 350086993)
110. R.J. Grill User-defined variables that affect outcome in spinal cord contusion/compression models Exp Neurol 196 1 2005 1 5 (Pubitemid 41416643)
111. D. Gris, E.F. Hamilton, and L.C. Weaver The systemic inflammatory response after spinal cord injury damages lungs and kidneys Exp Neurol 211 1 2008 259 270
112. M.E. Gurney, F.B. Cutting, P. Zhai, A. Doble, C.P. Taylor, and P.K. Andrus Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis [see comments] Ann Neurol 39 2 1996 147 157 (Pubitemid 26071564)
113. A.P. Halestrap, C.P. Connern, E.J. Griffiths, and P.M. Kerr Cyclosporin A binding to mitochondrial cyclophilin inhibits the permeability transition pore and protects hearts from ischaemia/reperfusion injury Mol Cell Biochem 174 1-2 1997 167 172 (Pubitemid 27404185)
114. A.P. Halestrap, K.Y. Woodfield, and C.P. Connern Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase J Biol Chem 272 6 1997 3346 3354
115. A.P. Halestrap, G.P. McStay, and S.J. Clarke The permeability transition pore complex: another view Biochimie 84 2-3 2002 153 166
116. A.P. Halestrap, and C. Brennerb The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death Curr Med Chem 10 16 2003 1507 1525 (Pubitemid 36896553)
117. E.D. Hall, and J.M. Braughler Effects of intravenous methylprednisolone on spinal cord lipid peroxidation and Na+ + K+)-ATPase activity. Dose-response analysis during 1st hour after contusion injury in the cat J Neurosurg 57 2 1982 247 253 (Pubitemid 12099610)
118. E.D. Hall The neuroprotective pharmacology of methylprednisolone J Neurosurg 76 1 1992 13 22
119. E.D. Hall Lipid antioxidants in acute central nervous system injury Ann Emerg Med 22 6 1993 1022 1027 (Pubitemid 23163045)
120. E.D. Hall, and J.E. Springer Neuroprotection and acute spinal cord injury: a reappraisal NeuroRx 1 1 2004 80 100 (Pubitemid 46589342)
121. R.R. Hansebout, A.R. Blight, S. Fawcett, and K. Reddy 4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients J Neurotrauma 10 1 1993 1 18 (Pubitemid 23153141)
122. M.J. Hansson, T. Persson, H. Friberg, M.F. Keep, A. Rees, and T. Wieloch Powerful cyclosporin inhibition of calcium-induced permeability transition in brain mitochondria Brain Res 960 1-2 2003 99 111 (Pubitemid 36044567)
123. M.J. Hansson, G. Mattiasson, R. Mansson, J. Karlsson, M.F. Keep, and P. Waldmeier The nonimmunosuppressive cyclosporin analogs NIM811 and UNIL025 display nanomolar potencies on permeability transition in brain-derived mitochondria J Bioenerg Biomembr 36 4 2004 407 413 (Pubitemid 39619849)
124. J. Hatton, B. Rosbolt, P. Empey, R. Kryscio, and B. Young Dosing and safety of cyclosporine in patients with severe brain injury J Neurosurg 109 4 2008 699 707
125. G.W. Hawryluk, J. Rowland, B.K. Kwon, and M.G. Fehlings Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury Neurosurg Focus 25 5 2008 E14
126. K.C. Hayes, A.R. Blight, P.J. Potter, R.D. Allatt, J.T. Hsieh, and D.L. Wolfe Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury Paraplegia 31 4 1993 216 224 (Pubitemid 23264674)
127. K.C. Hayes, P.J. Potter, D.L. Wolfe, J.T. Hsieh, G.A. Delaney, and A.R. Blight 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury J Neurotrauma 11 4 1994 433 446 (Pubitemid 24304694)
128. K.C. Hayes, M.A. Katz, J.G. Devane, J.T. Hsieh, D.L. Wolfe, and P.J. Potter Pharmacokinetics of an immediate-release oral formulation of fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injury J Clin Pharmacol 43 4 2003 379 385 (Pubitemid 36368779)
129. K.C. Hayes, P.J. Potter, R.R. Hansebout, J.M. Bugaresti, J.T. Hsieh, and S. Nicosia Pharmacokinetic studies of single and multiple oral doses of fampridine-SR (sustained-release 4-aminopyridine) in patients with chronic spinal cord injury Clin Neuropharmacol 26 4 2003 185 192 (Pubitemid 36951063)
130. K.C. Hayes The use of 4-aminopyridine (fampridine) in demyelinating disorders CNS Drug Rev 10 4 2004 295 316 (Pubitemid 40128914)
131. K.C. Hayes, P.J. Potter, J.T. Hsieh, M.A. Katz, A.R. Blight, and R. Cohen Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury Arch Phys Med Rehabil 85 1 2004 29 34 (Pubitemid 38049587)
132. T.X. Hoang, M. Akhavan, J. Wu, and L.A. Havton Minocycline protects motor but not autonomic neurons after cauda equina injury Exp Brain Res 189 1 2008 71 77
133. W.-H. Hu, H. Johnson, and H.-B. Shu Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappa B and JNK activation and apoptosis through distinct pathways J Biol Chem 274 43 1999 30603 30610
134. Y. Hu, M.A. Benedict, L. Ding, and G. Nunez Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase- 9 activation and apoptosis EMBO J 18 13 1999 3586 3595 (Pubitemid 29308839)
135. H. Huang, S. Fan, X. Ji, Y. Zhang, F. Bao, and G. Zhang Recombinant human erythropoietin protects against experimental spinal cord trauma injury by regulating expression of the proteins MKP-1 and p-ERK J Int Med Res 37 2 2009 511 519
136. J.P. Hubert, and A. Doble Ibotenic acid stimulates D-[3H]aspartate release from cultured cerebellar granule cells Neurosci Lett 96 3 1989 345 350 (Pubitemid 19026705)
137. J.P. Hubert, J.C. Delumeau, J. Glowinski, J. Premont, and A. Doble Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action Br J Pharmacol 113 1 1994 261 267 (Pubitemid 24271747)
138. R.J. Hurlbert Methylprednisolone for acute spinal cord injury: an inappropriate standard of care J Neurosur 93 1 Suppl 2000 1 7
139. A. Ibarra, G. Guizar-Sahagun, D. Correa, R. Kretschmer, I. Grijalva, and F.J. Flores-Murrieta Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury J Neurotrauma 13 5 1996 267 272 (Pubitemid 26192774)
140. A. Ibarra, J. Reyes, S. Martinez, D. Correa, G. Guizar-Sahagun, and I. Grijalva Use of cyclosporin-A in experimental spinal cord injury: design of a dosing strategy to maintain therapeutic levels J Neurotrauma 13 10 1996 569 572 (Pubitemid 26377855)
141. A. Ibarra, D. Correa, K. Willms, M.T. Merchant, G. Guizar-Sahagun, and I. Grijalva Effects of cyclosporin-A on immune response, tissue protection and motor function of rats subjected to spinal cord injury Brain Res 979 1-2 2003 165 178 (Pubitemid 36792167)
142. W. Jelkmann Erythropoietin: structure, control of production, and function Physiol Rev 72 2 1992 449 489
143. R.E. Jones, J.R. Heron, D.H. Foster, R.S. Snelgar, and R.J. Mason Effects of 4-aminopyridine in patients with multiple sclerosis J Neurol Sci 60 3 1983 353 362 (Pubitemid 13051185)
144. N.J. Kachuck Sustained release oral fampridine in the treatment of multiple sclerosis Expert Opin Pharmacother 10 12 2009 2025 2035
145. E. Kaptanoglu, I. Solaroglu, O. Okutan, H.S. Surucu, F. Akbiyik, and E. Beskonakli Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: effect on lipid peroxidation and early ultrastructural findings Neurosurg Rev 27 2 2004 113 120 (Pubitemid 38374415)
146. M. Kawakami, M. Sekiguchi, K. Sato, S. Kozaki, and M. Takahashi Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia J Biol Chem 276 42 2001 39469 39475
147. P.H. Kitzman Effectiveness of riluzole in suppressing spasticity in the spinal cord injured rat Neurosci Lett 455 2 2009 150 153
148. J.Y. Koh, D.K. Kim, J.Y. Hwang, Y.H. Kim, and J.H. Seo Antioxidative and proapoptotic effects of riluzole on cultured cortical neurons J Neurochem 72 2 1999 716 723 (Pubitemid 29055235)
149. Y. Konishi, D.H. Chui, H. Hirose, T. Kunishita, and T. Tabira Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro and in vivo Brain Res 609 1-2 1993 29 35 (Pubitemid 23136796)
150. M.J. Koury, and M.C. Bondurant The molecular mechanism of erythropoietin action Eur J Biochem 210 3 1992 649 663 (Pubitemid 23015763)
151. G. Kroemer, B. Dallaporta, and M. Resche-Rigon The mitochondrial death/life regulator in apoptosis and necrosis Annu Rev Physiol 60 1998 619 642 (Pubitemid 28157889)
152. G. Kroemer, and J. Reed Mitochondrial control of cell death Nat Med 6 5 2000 513 519 (Pubitemid 30305900)
153. D. Lammertse, M.H. Tuszynski, J.D. Steeves, A. Curt, J.W. Fawcett, and C. Rask Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial design Spinal Cord 45 3 2007 232 242 (Pubitemid 46340851)
154. L. Lang-Lazdunski, C. Heurteaux, A. Mignon, J. Mantz, C. Widmann, and J. Desmonts Ischemic spinal cord injury induced by aortic cross-clamping: prevention by riluzole Eur J Cardiothorac Surg 18 2 2000 174 181 (Pubitemid 30488814)
155. S.M. Lee, T.Y. Yune, S.J. Kim, D.W. Park, Y.K. Lee, and Y.C. Kim Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat J Neurotrauma 20 10 2003 1017 1027 (Pubitemid 37288561)
156. M. Leist, P. Ghezzi, G. Grasso, R. Bianchi, P. Villa, and M. Fratelli Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 5681 2004 239 242 (Pubitemid 38886736)
157. F. Li, A. Srinivasan, Y. Wang, R.C. Armstrong, K.J. Tomaselli, and L.C. Fritz Cell-specific induction of apoptosis by microinjection of cytochrome c. Bcl-xL has activity independent of cytochrome c release J Biol Chem 272 48 1997 30299 30305 (Pubitemid 27512235)
158. H. Li, L. Bergeron, V. Cryns, M.S. Pasternack, H. Zhu, and L. Shi Activation of caspase-2 in apoptosis J Biol Chem 272 34 1997 21010 21017 (Pubitemid 27373957)
159. J. Li, T.R. Billiar, R.V. Talanian, and Y.M. Kim Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation Biochem Biophys Res Commun 240 2 1997 419 424 (Pubitemid 27523676)
160. L.Y. Li, X. Luo, and X. Wang Endonuclease G is an apoptotic DNase when released from mitochondria Nature 412 6842 2001 95 99 (Pubitemid 32851517)
161. M. Li, X. Wu, and X.C. Xu Induction of apoptosis by cyclo-oxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway in esophageal cancer cells Int J Cancer 93 2 2001 218 223 (Pubitemid 32574278)
162. M. Li, X. Wu, and X.C. Xu Induction of apoptosis in colon cancer cells by cyclooxygenase-2 inhibitor NS398 through a cytochrome c-dependent pathway Clin Cancer Res 7 4 2001 1010 1016 (Pubitemid 32708740)
163. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, and E.S. Alnemri Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 4 1997 479 489 (Pubitemid 27508237)
164. P.A. Li, H. Uchino, E. Elmer, and B.K. Siesjo Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia Brain Res 753 1 1997 133 140 (Pubitemid 27156143)
165. S. Li, and P.K. Stys Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter J Neurosci 20 3 2000 1190 1198 (Pubitemid 30220475)
166. S. Li, and C.H. Tator Action of locally administered NMDA and AMPA/kainate receptor antagonists in spinal cord injury Neurol Res 22 2 2000 171 180 (Pubitemid 30180796)
167. T.N. Lin, G.M. Kim, J.J. Chen, W.M. Cheung, Y.Y. He, and C.Y. Hsu Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion Stroke 34 1 2003 177 186 (Pubitemid 36070819)
168. S.A. Lipton Molecular mechanisms of trauma-induced neuronal degeneration Curr Opin Neurol Neurosurg 6 4 1993 588 596 (Pubitemid 23232826)
169. S.A. Lipton, and P.A. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N Engl J Med 330 9 1994 613 622
170. S.A. Lipton, and P. Nicotera Calcium, free radicals and excitotoxins in neuronal apoptosis Cell Calcium 23 2-3 1998 165 171 (Pubitemid 28190033)
171. D. Liu, W. Thangnipon, and D.J. McAdoo Excitatory amino acids rise to toxic levels upon impact injury to the rat spinal cord Brain Res 547 2 1991 344 348
172. D. Liu, G.Y. Xu, E. Pan, and D.J. McAdoo Neurotoxicity of glutamate at the concentration released upon spinal cord injury Neuroscience 93 4 1999 1383 1389 (Pubitemid 29397567)
173. S. Liu, G.L. Ruenes, and R.P. Yezierski NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord Brain Res 756 1-2 1997 160 167 (Pubitemid 27241621)
174. X. Liu, C.N. Kim, J. Yang, R. Jemmerson, and X. Wang Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c Cell 86 1 1996 147 157 (Pubitemid 26256586)
175. J. Long, C. Liu, L. Sun, H. Gao, and J. Liu Neuronal mitochondrial toxicity of malondialdehyde: inhibitory effects on respiratory function and enzyme activities in rat brain mitochondria Neurochem Res 34 4 2009 786 794
176. S. Lowitt, J.I. Malone, A.F. Salem, J. Korthals, and S. Benford Acetyl-l-carnitine corrects the altered peripheral nerve function of experimental diabetes Metabolism 44 5 1995 677 680
177. J. Luo, and R. Shi Acrolein induces axolemmal disruption, oxidative stress, and mitochondrial impairment in spinal cord tissue Neurochem Int 44 7 2004 475 486 (Pubitemid 38183298)
178. P.J. Mabon, L.C. Weaver, and G.A. Dekaban Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alpha D: a potential new anti- inflammatory treatment Exp Neurol 166 1 2000 52 64
179. C. Malgouris, F. Bardot, M. Daniel, F. Pellis, J. Rataud, and A. Uzan Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils J Neurosci 9 11 1989 3720 3727 (Pubitemid 20004867)
180. J. Mantz, A. Cheramy, A.M. Thierry, J. Glowinski, and J.M. Desmonts Anesthetic properties of riluzole (54274 RP), a new inhibitor of glutamate neurotransmission Anesthesiology 76 5 1992 844 848
181. J. Mantz, V. Laudenbach, J.B. Lecharny, D. Henzel, and J.M. Desmonts Riluzole, a novel antiglutamate, blocks GABA uptake by striatal synaptosomes Eur J Pharmacol 257 1-2 1994 R7 R8 (Pubitemid 24178544)
182. N.J. Maragakis, and J.D. Rothstein Glutamate transporters: animal models to neurologic disease Neurobiol Dis 15 3 2004 461 473 (Pubitemid 38429961)
183. F. Marchand, C. Tsantoulas, D. Singh, J. Grist, A.K. Clark, and E.J. Bradbury Effects of etanercept and minocycline in a rat model of spinal cord injury Eur J Pain 13 7 2009 673 681
184. M.M. Marcus, G.G. Nomikos, and T.H. Svensson Differential actions of typical and atypical antipsychotic drugs on dopamine release in the core and shell of the nucleus accumbens Eur Neuropsychopharmacol 6 1 1996 29 38 (Pubitemid 26099130)
185. A.L. Markowska, D.K. Ingram, C.A. Barnes, E.L. Spangler, V.J. Lemken, and H. Kametani Acetyl-l-carnitine. 1: effects on mortality, pathology and sensory-motor performance in aging rats Neurobiol Aging 11 5 1990 491 498 (Pubitemid 20297141)
186. D. Martin, M.A. Thompson, and J.V. Nadler The neuroprotective agent riluzole inhibits release of glutamate and aspartate from slices of hippocampal area CA1 Eur J Pharmacol 250 3 1993 473 476 (Pubitemid 24010985)
187. E. Martin, R.E. Rosenthal, and G. Fiskum Pyruvate dehydrogenase complex: metabolic link to ischemic brain injury and target of oxidative stress J Neurosci Res 79 1-2 2005 240 247 (Pubitemid 40116441)
188. S. Matsumoto, H. Friberg, M. Ferrand-Drake, and T. Wieloch Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion J Cereb Blood Flow Metab 19 7 1999 736 741 (Pubitemid 30159798)
189. A.T. Mazzeo, G.M. Brophy, C.B. Gilman, O.L. Alves, J.R. Robles, and R.L. Hayes Safety and tolerability of cyclosporin a in severe traumatic brain injury patients: results from a prospective randomized trial J Neurotrauma 26 12 2009 2195 2206
190. D.J. McAdoo, G.Y. Xu, G. Robak, and M.G. Hughes Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord Exp Neurol 159 2 1999 538 544 (Pubitemid 29485240)
191. D.J. McAdoo, G. Xu, G. Robak, M.G. Hughes, and E.M. Price Evidence that reversed glutamate uptake contributes significantly to glutamate release following experimental injury to the rat spinal cord Brain Res 865 2 2000 283 285 (Pubitemid 30256009)
192. D.J. McAdoo, M.G. Hughes, L. Nie, B. Shah, C. Clifton, and S. Fullwood The effect of glutamate receptor blockers on glutamate release following spinal cord injury. Lack of evidence for an ongoing feedback cascade of damage -> glutamate release -> damage -> glutamate release -> etc Brain Res 1038 1 2005 92 99 (Pubitemid 40340965)
193. M.A. McDaniel, S.F. Maier, and G.O. Einstein "Brain-specific" nutrients: a memory cure? Nutrition 19 11-12 2003 957 975
194. M.L. McEwen, P.G. Sullivan, and J.E. Springer Pretreatment with the cyclopsorin derivative, NIM811, improves the function of synaptic mitochondria following spinal cord contusion in rats J Neurotrauma 24 4 2007 613 624 (Pubitemid 46996022)
195. M.L. McEwen, P.G. Sullivan, A.G. Rabchevsky, and J.E. Springer Targeting mitochondrial function for the treatment of acute spinal cord injury Neurotherapeutics 8 2 2011 168 179
196. T.K. McIntosh, D.H. Smith, M. Voddi, B.R. Perri, and J.M. Stutzmann Riluzole, a novel neuroprotective agent, attenuates both neurologic motor and cognitive dysfunction following experimental brain injury in the rat J Neurotrauma 13 12 1996 767 780 (Pubitemid 27043978)
197. J. Mizoule, B. Meldrum, M. Mazadier, M. Croucher, C. Ollat, and A. Uzan 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission-I. Anticonvulsant properties Neuropharmacology 24 8 1985 767 773 (Pubitemid 15239052)
198. D.A. Morgenstern, R.A. Asher, and J.W. Fawcett Chondroitin sulphate proteoglycans in the CNS injury response Prog Brain Res 137 2002 313 332 (Pubitemid 35460952)
199. X. Mu, R.D. Azbill, and J.E. Springer Riluzole improves measures of oxidative stress following traumatic spinal cord injury Brain Res 870 1-2 2000 66 72 (Pubitemid 30408404)
200. X. Mu, R.D. Azbill, and J.E. Springer Riluzole and methylprednisolone combined treatment improves functional recovery in traumatic spinal cord injury J Neurotrauma 17 9 2000 773 780
201. N.M. Murray, and J. Newsom-Davis Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission Neurology 31 3 1981 265 271 (Pubitemid 11146987)
202. S. Nagel, Y. Su, S. Horstmann, S. Heiland, H. Gardner, and J. Koziol Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat: effects on BBB breakdown and MMP expression in the acute and subacute phase Brain Res 1188 2008 198 206 (Pubitemid 350296055)
203. T. Nakagawa, S. Shimizu, T. Watanabe, O. Yamaguchi, K. Otsu, and H. Yamagata Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death Nature 434 7033 2005 652 658 (Pubitemid 40488558)
204. A. Nicolli, E. Basso, V. Petronilli, R.M. Wenger, and P. Bernardi Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, and cyclosporin A-sensitive channel J Biol Chem 271 4 1996 2185 2192 (Pubitemid 26047809)
205. A. Nogradi, A. Szabo, S. Pinter, and G. Vrbova Delayed riluzole treatment is able to rescue injured rat spinal motoneurons Neuroscience 144 2 2007 431 438 (Pubitemid 44873042)
206. S.M. Onifer, A.G. Rabchevsky, and S.W. Scheff Rat models of traumatic spinal cord injury to assess motor recovery ILAR J 48 4 2007 385 395 (Pubitemid 350194370)
207. M. Onofrj, T. Fulgente, D. Melchionda, A. Marchionni, F. Tomasello, and F.M. Salpietro l-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain Int J Clin Pharmacol Res 15 1 1995 9 15
208. G. Onose, A. Anghelescu, D.F. Muresanu, L. Padure, M.A. Haras, and C.O. Chendreanu A review of published reports on neuroprotection in spinal cord injury Spinal Cord 47 10 2009 716 726
209. W.O. Opii, V.N. Nukala, R. Sultana, J.D. Pandya, K.M. Day, and M.L. Merchant Proteomic identification of oxidized mitochondrial proteins following experimental traumatic brain injury J Neurotrauma 24 5 2007 772 789 (Pubitemid 46799270)
210. M. Oudega, C.G. Vargas, A.B. Weber, N. Kleitman, and M.B. Bunge Long-term effects of methylprednisolone following transection of adult rat spinal cord Eur J Neurosci 11 7 1999 2453 2464 (Pubitemid 29292340)
211. S.S. Panter, S.W. Yum, and A.I. Faden Alteration in extracellular amino acids after traumatic spinal cord injury Ann Neurol 27 1 1990 96 99 (Pubitemid 20031364)
212. L. Parnetti, A. Gaiti, P. Mecocci, D. Cadini, and U. Senin Pharmacokinetics of IV and oral acetyl-l-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type Eur J Clin Pharmacol 42 1 1992 89 93
213. S.P. Patel, P.G. Sullivan, J.D. Pandya, and A.G. Rabchevsky Differential effects of the mitochondrial uncoupling agent, 2,4-dinitrophenol, or the nitroxide antioxidant, Tempol, on synaptic or nonsynaptic mitochondria after spinal cord injury J Neurosci Res 87 1 2009 130 140
214. S.P. Patel, P.G. Sullivan, T.S. Lyttle, and A.G. Rabchevsky Acetyl-l-carnitine ameliorates mitochondrial dysfunction following contusion spinal cord injury J Neurochem 114 1 2010 291 301
215. V. Petronilli, D. Penzo, L. Scorrano, P. Bernardi, and F. Di Lisa The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ J Biol Chem 276 15 2001 12030 12034
216. J.W. Pettegrew, J. Levine, and R.J. McClure Acetyl-l-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression Mol Psychiatry 5 6 2000 616 632
217. A. Pinzon, A. Marcillo, D. Pabon, H.M. Bramlett, M.B. Bunge, and W.D. Dietrich A re-assessment of erythropoietin as a neuroprotective agent following rat spinal cord compression or contusion injury Exp Neurol 213 1 2008 129 136
218. A. Pinzon, A. Marcillo, A. Quintana, S. Stamler, M.B. Bunge, and H.M. Bramlett A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model Brain Res 1243 2008 146 151
219. C.H. Polman, F.W. Bertelsmann, R. de Waal, H.A. van Diemen, B.M. Uitdehaag, and A.C. van Loenen 4-Aminopyridine is superior to 3,4-diaminopyridine in the treatment of patients with multiple sclerosis Arch Neurol 51 11 1994 1136 1139 (Pubitemid 24352857)
220. C.H. Polman, F.W. Bertelsmann, A.C. van Loenen, and J.C. Koetsier 4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety Arch Neurol 51 3 1994 292 296 (Pubitemid 24088417)
221. B.M. Polster, and G. Fiskum Mitochondrial mechanisms of neural cell apoptosis J Neurochem 90 6 2004 1281 1289 (Pubitemid 39223632)
222. P.G. Popovich, and E.E. Longbrake Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci 9 6 2008 481 493 (Pubitemid 351704948)
223. P.J. Potter, K.C. Hayes, J.T. Hsieh, G.A. Delaney, and J.L. Segal Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases Spinal Cord 36 3 1998 147 155 (Pubitemid 28120689)
224. P.J. Potter, K.C. Hayes, J.L. Segal, J.T. Hsieh, S.R. Brunnemann, and G.A. Delaney Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury J Neurotrauma 15 10 1998 837 849 (Pubitemid 28487997)
225. F.M. Puca, S. Genco, L.M. Specchio, B. Brancasi, R. D'Ursi, and A. Prudenzano Clinical pharmacodynamics of acetyl-l-carnitine in patients with Parkinson's disease Int J Clin Pharmacol Res 10 1-2 1990 139 143 (Pubitemid 20377890)
226. A.G. Rabchevsky, and W.J. Streit Role of microglia in postinjury repair and regeneration of the CNS MRDD Res Rev 4 1998 187 192 (Pubitemid 28420569)
227. A.G. Rabchevsky, I. Fugaccia, P.G. Sullivan, and S.W. Scheff Cyclosporin A treatment following spinal cord injury to the rat: behavioral effects and stereological assessment of tissue sparing J Neurotrauma 18 5 2001 513 522 (Pubitemid 32472841)
228. A.G. Rabchevsky, and G.M. Smith Therapeutic interventions following mammalian spinal cord injury Arch Neurol 58 5 2001 721 726 (Pubitemid 32423043)
229. A.G. Rabchevsky, I. Fugaccia, P.G. Sullivan, D.A. Blades, and S.W. Scheff Efficacy of methylprednisolone therapy for the injured rat spinal cord J Neurosci Res 68 1 2002 7 18 (Pubitemid 34274992)
230. G. Rai, G. Wright, L. Scott, B. Beston, J. Rest, and A.N. Exton-Smith Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia Curr Med Res Opin 11 10 1990 638 647
231. O. Raisky, L. Gomez, L. Chalabreysse, O. Gateau-Roesch, J. Loufouat, and F. Thivolet-Bejui Mitochondrial permeability transition in cardiomyocyte apoptosis during acute graft rejection Am J Transplant 4 7 2004 1071 1078 (Pubitemid 38868596)
232. R. Ravikumar, M.L. McEwen, and J.E. Springer Post-treatment with the cyclosporin derivative, NIM811, reduced indices of cell death and increased the volume of spared tissue in the acute period following spinal cord contusion J Neurotrauma 24 10 2007 1618 1630 (Pubitemid 350035843)
233. J.C. Reed, and G. Kroemer Mechanisms of mitochondrial membrane permeabilization Cell Death Differ 7 12 2000 1145 (Pubitemid 32042220)
234. L.J. Reed Regulation of mammalian pyruvate dehydrogenase complex by a phosphorylation-dephosphorylation cycle Curr Top Cell Regul 18 1981 95 106
235. L.J. Reed A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes J Biol Chem 276 42 2001 38329 38336
236. S. Rossignol, M. Schwab, M. Schwartz, and M.G. Fehlings Spinal cord injury: time to move? J Neurosci 27 44 2007 11782 11792 (Pubitemid 350072087)
237. S.K. Roy Chowdhury, G.V. Sangle, X. Xie, G.L. Stelmack, A.J. Halayko, and G.X. Shen Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells Am J Physiol Endocrinol Metab 2009
238. K. Saganova, J. Orendacova, D. Cizkova, and I. Vanicky Limited minocycline neuroprotection after balloon-compression spinal cord injury in the rat Neurosci Lett 433 3 2008 246 249
239. M. Sakanaka, T.C. Wen, S. Matsuda, S. Masuda, E. Morishita, and M. Nagao In vivo evidence that erythropoietin protects neurons from ischemic damage Proc Natl Acad Sci USA 95 8 1998 4635 4640 (Pubitemid 28207965)
240. R.O. Sanchez Mejia, V.O. Ona, M. Li, and R.M. Friedlander Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction Neurosurgery 48 6 2001 1399 1401 discussion
241. D.B. Sanders, Y.I. Kim, J.F. Howard Jr., and C.A. Goetsch Eaton-Lambert syndrome: a clinical and electrophysiological study of a patient treated with 4-aminopyridine J Neurol Neurosurg Psychiatry 43 11 1980 978 985 (Pubitemid 11217271)
242. M. Sano, K. Bell, L. Cote, G. Dooneief, A. Lawton, and L. Legler Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease Arch Neurol 49 11 1992 1137 1141
243. S.W. Scheff, and P.G. Sullivan Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents J Neurotrauma 16 9 1999 783 792
244. A.C. Schinzel, O. Takeuchi, Z. Huang, J.K. Fisher, Z. Zhou, and J. Rubens Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia Proc Natl Acad Sci USA 102 34 2005 12005 12010 (Pubitemid 41291119)
245. M.E. Schwab Repairing the injured spinal cord Science 295 5557 2002 1029 1031 (Pubitemid 34132224)
246. G. Schwartz, and M.G. Fehlings Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole J Neurosurg 94 2 Suppl 2001 245 256 (Pubitemid 32786052)
247. G. Schwartz, and M.G. Fehlings Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole Prog Brain Res 137 2002 177 190 (Pubitemid 35460945)
248. S.R. Schwid, M.D. Petrie, M.P. McDermott, D.S. Tierney, D.H. Mason, and A.D. Goodman Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis Neurology 48 4 1997 817 821
249. L. Scorrano, A. Nicolli, E. Basso, V. Petronilli, and P. Bernardi Two modes of activation of the permeability transition pore: the role of mitochondrial cyclophilin Mol Cell Biochem 174 1-2 1997 181 184
250. L. Scorrano, V. Petronilli, and P. Bernardi On the voltage dependence of the mitochondrial permeability transition pore. A critical appraisal J Biol Chem 272 19 1997 12295 12299 (Pubitemid 27203313)
251. J.L. Segal, and S.R. Brunnemann 4-Aminopyridine alters gait characteristics and enhances locomotion in spinal cord injured humans J Spinal Cord Med 21 3 1998 200 204 (Pubitemid 128735588)
252. A.L. Sheldon, and M.B. Robinson The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention Neurochem Int 51 6-7 2007 333 355 (Pubitemid 47503456)
253. R. Shi, and A.R. Blight Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord Neuroscience 77 2 1997 553 562 (Pubitemid 27079623)
254. D.J. Short, W.S. El Masry, and P.W. Jones High dose methylprednisolone in the management of acute spinal cord injury - a systematic review from a clinical perspective Spinal Cord 38 5 2000 273 286 (Pubitemid 30307193)
255. A.A. Sima, H. Ristic, A. Merry, M. Kamijo, S.A. Lattimer, and M.J. Stevens Primary preventive and secondary interventionary effects of acetyl-l-carnitine on diabetic neuropathy in the bio-breeding Worcester rat J Clin Invest 97 8 1996 1900 1907
256. K.D. Sims, and M.B. Robinson Expression patterns and regulation of glutamate transporters in the developing and adult nervous system Crit Rev Neurobiol 13 2 1999 169 197 (Pubitemid 29431429)
257. A.L. Siren, M. Fratelli, M. Brines, C. Goemans, S. Casagrande, and P. Lewczuk Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Proc Natl Acad Sci USA 98 7 2001 4044 4049 (Pubitemid 32249895)
258. J.H. Song, C.S. Huang, K. Nagata, J.Z. Yeh, and T. Narahashi Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels J Pharmacol Exp Ther 282 2 1997 707 714 (Pubitemid 27340171)
259. A. Spagnoli, U. Lucca, G. Menasce, L. Bandera, G. Cizza, and G. Forloni Long-term acetyl-l-carnitine treatment in Alzheimer's disease Neurology 41 11 1991 1726 1732
260. D.A. Spyker, C. Lynch, J. Shabanowitz, and J.A. Sinn Poisoning with 4-aminopyridine: report of three cases Clin Toxicol 16 4 1980 487 497 (Pubitemid 10048631)
261. J.D. Steeves, D. Lammertse, A. Curt, J.W. Fawcett, M.H. Tuszynski, and J.F. Ditunno Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures Spinal Cord 45 3 2007 206 221 (Pubitemid 46340849)
262. A. Stefani, F. Spadoni, and G. Bernardi Differential inhibition by riluzole, lamotrigine, and phenytoin of sodium and calcium currents in cortical neurons: implications for neuroprotective strategies Exp Neurol 147 1 1997 115 122 (Pubitemid 27402448)
263. D. Stefoski, F.A. Davis, W.E. Fitzsimmons, S.S. Luskin, J. Rush, and G.W. Parkhurst 4-Aminopyridine in multiple sclerosis: prolonged administration Neurology 41 9 1991 1344 1348
264. O. Steward, K. Sharp, G. Selvan, A. Hadden, M. Hofstadter, and E. Au A re-assessment of the consequences of delayed transplantation of olfactory lamina propria following complete spinal cord transection in rats Exp Neurol 198 2 2006 483 499
265. O. Steward, K. Sharp, K.M. Yee, and M. Hofstadter A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice Exp Neurol 209 2 2008 446 468
266. D.P. Stirling, K. Khodarahmi, J. Liu, L.T. McPhail, C.B. McBride, and J.D. Steeves Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury J Neurosci 24 9 2004 2182 2190 (Pubitemid 38314550)
267. D.P. Stirling, K.M. Koochesfahani, J.D. Steeves, and W. Tetzlaff Minocycline as a neuroprotective agent Neuroscientist 11 4 2005 308 322 (Pubitemid 41040860)
268. B.T. Stokes, and L.B. Jakeman Experimental modelling of human spinal cord injury: a model that crosses the species barrier and mimics the spectrum of human cytopathology Spinal Cord 40 3 2002 101 109 (Pubitemid 34188275)
269. A.K. Stout, H.M. Raphael, B.I. Kanterewicz, E. Klann, and I.J. Reynolds Glutamate-induced neuron death requires mitochondrial calcium uptake Nat Neurosci 1 5 1998 366 373
270. J.M. Stutzmann, J. Pratt, T. Boraud, and C. Gross The effect of riluzole on post-traumatic spinal cord injury in the rat Neuroreport 7 2 1996 387 392 (Pubitemid 26105006)
271. P.G. Sullivan, M.B. Thompson, and S.W. Scheff Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury Exp Neurol 160 1 1999 226 234
272. P.G. Sullivan, J.D. Geiger, M.P. Mattson, and S.W. Scheff Dietary supplement creatine protects against traumatic brain injury Ann Neurol 48 5 2000 723 729
273. P.G. Sullivan, A.G. Rabchevsky, R.R. Hicks, T.R. Gibson, A. Fletcher-Turner, and S.W. Scheff Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats Neuroscience 101 2 2000 289 295
274. P.G. Sullivan, M. Thompson, and S.W. Scheff Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury Exp Neurol 161 2 2000 631 637 (Pubitemid 30137020)
275. P.G. Sullivan, A.G. Rabchevsky, J.N. Keller, M. Lovell, A. Sodhi, and R.P. Hart Intrinsic differences in brain and spinal cord mitochondria: Implication for therapeutic interventions J Comp Neurol 474 4 2004 524 534 (Pubitemid 38720422)
276. P.G. Sullivan, A.G. Rabchevsky, P.C. Waldmeier, and J.E. Springer Mitochondrial permeability transition in CNS trauma: cause or effect of neuronal cell death? J Neurosci Res 79 1-2 2005 231 239 (Pubitemid 40116440)
277. P.G. Sullivan, S. Krishnamurthy, S.P. Patel, J.D. Pandya, and A.G. Rabchevsky Temporal characterization of mitochondrial bioenergetics after spinal cord injury J Neurotrauma 24 6 2007 991 999 (Pubitemid 47015433)
278. S. Swamy-Mruthinti, and A.L. Carter Acetyl-l-carnitine decreases glycation of lens proteins: in vitro studies Exp Eye Res 69 1 1999 109 115 (Pubitemid 29335457)
279. I. Szabo, and M. Zoratti The mitochondrial megachannel is the permeability transition pore J Bioenerg Biomembr 24 1 1992 111 117
280. Y. Taoka, K. Okajima, M. Uchiba, and M. Johno Methylprednisolone reduces spinal cord injury in rats without affecting tumor necrosis factor-a production J Neurotrauma 18 5 2001 533 543 (Pubitemid 32472843)
281. E. Tempesta, L. Casella, C. Pirrongelli, L. Janiri, M. Calvani, and L. Ancona l-Acetylcarnitine in depressed elderly subjects. A cross-over study vs placebo Drugs Exp Clin Res 13 7 1987 417 423 (Pubitemid 17125265)
282. Y.D. Teng, H. Choi, R.C. Onario, S. Zhu, F.C. Desilets, and S. Lan Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury Proc Natl Acad Sci USA 101 9 2004 3071 3076 (Pubitemid 38327736)
283. S. Thuret, L.D. Moon, and F.H. Gage Therapeutic interventions after spinal cord injury Nat Rev Neurosci 7 8 2006 628 643 (Pubitemid 44106745)
284. T. Tikka, B.L. Fiebich, G. Goldsteins, R. Keinanen, and J. Koistinaho Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia J Neurosci 21 8 2001 2580 2588 (Pubitemid 32298200)
285. V. Tomassini, C. Pozzilli, E. Onesti, P. Pasqualetti, F. Marinelli, and A. Pisani Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial J Neurol Sci 218 1-2 2004 103 108 (Pubitemid 38169402)
286. G. Traina, R. Bernardi, M. Rizzo, M. Calvani, M. Durante, and M. Brunelli Acetyl-l-carnitine up-regulates expression of voltage-dependent anion channel in the rat brain Neurochem Int 48 8 2006 673 678 (Pubitemid 44389610)
287. M.H. Tuszynski, J.D. Steeves, J.W. Fawcett, D. Lammertse, M. Kalichman, and C. Rask Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: clinical trial inclusion/exclusion criteria and ethics Spinal Cord 45 3 2007 222 231 (Pubitemid 46340850)
288. H. Uchino, R. Minamikawa-Tachino, T. Kristian, G. Perkins, M. Narazaki, and B.K. Siesjo Differential neuroprotection by cyclosporin A and FK506 following ischemia corresponds with differing abilities to inhibit calcineurin and the mitochondrial permeability transition Neurobiol Dis 10 3 2002 219 233 (Pubitemid 35217576)
289. G. van Loo, P. Schotte, M. van Gurp, H. Demol, B. Hoorelbeke, and K. Gevaert Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation Cell Death Differ 8 12 2001 1136 1142 (Pubitemid 34048469)
290. M.E. Vazquez-Memije, R. Capin, A. Tolosa, and M. El-Hafidi Analysis of age-associated changes in mitochondrial free radical generation by rat testis Mol Cell Biochem 307 1-2 2008 23 30 (Pubitemid 350238643)
291. A. Virmani, and Z. Binienda Role of carnitine esters in brain neuropathology Mol Aspects Med 25 5-6 2004 533 549 (Pubitemid 39195075)
292. L. Vitellaro-Zuccarello, S. Mazzetti, L. Madaschi, P. Bosisio, A. Gorio, and S. De Biasi Erythropoietin-mediated preservation of the white matter in rat spinal cord injury Neuroscience 144 3 2007 865 877 (Pubitemid 46013988)
293. F. Wahl, E. Renou, V. Mary, and J.M. Stutzmann Riluzole reduces brain lesions and improves neurological function in rats after a traumatic brain injury Brain Res 756 1-2 1997 247 255 (Pubitemid 27241633)
294. P.C. Waldmeier, J.J. Feldtrauer, T. Qian, and J.J. Lemasters Inhibition of the mitochondrial permeability transition by the nonimmunosuppressive cyclosporin derivative NIM811 Mol Pharmacol 62 1 2002 22 29 (Pubitemid 34680512)
295. P.C. Waldmeier, K. Zimmermann, T. Qian, M. Tintelnot-Blomley, and J.J. Lemasters Cyclophilin D as a drug target Curr Med Chem 10 16 2003 1485 1506 (Pubitemid 36896552)
296. M. Watanabe, Y. Fujimura, M. Nakamura, Y. Yato, K. Ohta, and H. Okai Changes of amino acid levels and aspartate distribution in the cervical spinal cord after traumatic spinal cord injury J Neurotrauma 15 4 1998 285 293 (Pubitemid 28166580)
297. Y.H. Wei, S.B. Wu, Y.S. Ma, and H.C. Lee Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging Chang Gung Med J 32 2 2009 113 132
298. J.E. Wells, R.J. Hurlbert, M.G. Fehlings, and V.W. Yong Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice Brain 126 Pt 7 2003 1628 1637 (Pubitemid 36834939)
299. C. Wiessner, P.R. Allegrini, D. Ekatodramis, U.R. Jewell, T. Stallmach, and M. Gassmann Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin J Cereb Blood Flow Metab 21 7 2001 857 864 (Pubitemid 32613540)
300. Y.J. Won, J.Y. Yoo, J.H. Lee, S.J. Hwang, D. Kim, and H.N. Hong Erythropoietin is neuroprotective on GABAergic neurons against kainic acid-excitotoxicity in the rat spinal cell cultures Brain Res 1154 2007 31 39 (Pubitemid 46856347)
301. J.R. Wrathall, D. Choiniere, and Y.D. Teng Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA/kainate antagonist NBQX J Neurosci 14 11 Pt 1 1994 6598 6607 (Pubitemid 24333080)
302. J.R. Wrathall, Y.D. Teng, and D. Choiniere Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors Exp Neurol 137 1 1996 119 126 (Pubitemid 26041788)
303. J.R. Wrathall, Y.D. Teng, and R. Marriott Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma Exp Neurol 145 2 Pt 1 1997 565 573 (Pubitemid 27314807)
304. J. Xu, G. Fan, S. Chen, Y. Wu, X.M. Xu, and C.Y. Hsu Methylprednisolone inhibition of TNF-alpha expression and NF-kB activation after spinal cord injury in rats Brain Res Mol Brain Res 59 2 1998 135 142 (Pubitemid 28434496)
305. J.C. Yang, and G.A. Cortopassi Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c Free Radic Biol Med 24 4 1998 624 631 (Pubitemid 28150480)
306. N. Yazihan, K. Uzuner, B. Salman, M. Vural, T. Koken, and A. Arslantas Erythropoietin improves oxidative stress following spinal cord trauma in rats Injury 39 12 2008 1408 1413
307. W. Young, V. DeCrescito, E.S. Flamm, A.R. Blight, and J.A. Gruner Pharmacological therapy of acute spinal cord injury: studies of high dose methylprednisolone and naloxone Clin Neurosurgery 34 1988 675 697
308. W. Young The Therapeutic Window for Methylprednisolone Treatment of Acute Spinal Cord Injury: Implications for Cell Injury Mechanisms 1993 Raven Press, Ltd. New York
309. J. Yrjanheikki, R. Keinanen, M. Pellikka, T. Hokfelt, and J. Koistinaho Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia Proc Natl Acad Sci USA 95 26 1998 15769 15774 (Pubitemid 29018775)
310. J. Yrjanheikki, T. Tikka, R. Keinanen, G. Goldsteins, P.H. Chan, and J. Koistinaho A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window Proc Natl Acad Sci USA 96 23 1999 13496 13500
311. T.Y. Yune, J.Y. Lee, G.Y. Jung, S.J. Kim, M.H. Jiang, and Y.C. Kim Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury J Neurosci 27 29 2007 7751 7761 (Pubitemid 47093808)
312. E. Zaidan, K.F. Sheu, and N.R. Sims The pyruvate dehydrogenase complex is partially inactivated during early recirculation following short-term forebrain ischemia in rats J Neurochem 70 1 1998 233 241 (Pubitemid 28020848)
313. C. Zhang, R. Raghupathi, K.E. Saatman, D.H. Smith, J.M. Stutzmann, and F. Wahl Riluzole attenuates cortical lesion size, but not hippocampal neuronal loss, following traumatic brain injury in the rat J Neurosci Res 52 3 1998 342 349 (Pubitemid 28196651)
314. H. Zhang, H. Jia, J. Liu, N. Ao, B. Yan, and W. Shen Combined R-alpha-lipoic acid and acetyl-l-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease J Cell Mol Med 2008
315. S. Zhu, I.G. Stavrovskaya, M. Drozda, B.Y. Kim, V. Ona, and M. Li Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature 417 6884 2002 74 78 (Pubitemid 34498818)